Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the delta and omicron strains, though new mutation-specific antibody production dipped slightly, ...

Share on Pinterest Someone waits in line for a vaccination outside a mass vaccination center on August 23, 2021. Lisa Maree Williams/Getty Images The COVID-19 Infection Survey regularly tests a random ...

The delta variant of SARS-CoV-2, the virus that causes COVID-19, has been making headlines as it has quickly become the most prevalent strain in America. But other variants of the virus are still out ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...